NURIX THERAPEUTICS, INC. (NRIX)

26.14USD +3.24% (+0.82)

Over 1M: +2.4%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

26 27
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Free Cash Flow: -31.8M Q4 '21 — Free Cash Flow: -31.8M Q1 '22 — Free Cash Flow: -46.1M Q2 '22 — Free Cash Flow: -35.7M Q3 '22 — Free Cash Flow: -49.7M Q4 '22 — Free Cash Flow: -40.5M Q1 '23 — Free Cash Flow: -50.7M Q2 '23 — Free Cash Flow: -19.5M Q3 '23 — Free Cash Flow: -43.6M Q4 '23 — Free Cash Flow: 24.1M Q1 '24 — Free Cash Flow: -44.8M Q2 '24 — Free Cash Flow: -41.6M Q3 '24 — Free Cash Flow: -44.5M Q4 '24 — Free Cash Flow: -50.9M Q1 '25 — Free Cash Flow: -64.6M Q2 '25 — Free Cash Flow: -65.8M Q3 '25 — Free Cash Flow: -60.1M Q4 '25 — Free Cash Flow: -73M Q1 '26 — Free Cash Flow: -73M Q2 '26 — Free Cash Flow: -98.5M -75M -50M -25M 0 25M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Cost of Revenue Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 107.8%
OE margin -936.1%
Oper. margin -982.4%
ROIC -241.0%
Accruals -8.9%
Asset turnover 0.069×
EBITDA margin -959.0%
FCF margin -828.3%
OCF margin -798.8%
Profit margin -928.4%
ROA -63.7%
ROCE -77.9%
ROE -84.8%
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/Sales 65.2×
EV/OE -7.0×
P/C 9.4×
FCF yield -11.4%
P/B 6.7×
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.2
RPO / sales 0.36×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

7.0
ND/EBITDA 0.12
Cash runway 0.93 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 6.3×
F-score 3.9 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.2
Sales CAGR 4Y +29.6%
Sales/sh Y/Y -67.8%
Sales Q/Q -79.5%
Shares change +29.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.